IL10RA, which appeared to be expressed at lower levels in B cells of MS patients compared to healthy controls as previously reported [77], mediates the immunosuppressive signal of IL10 by inhibiting the expression of pro-inflammatory genes [78]. The gene discussed is IL10; the disease is myeloid sarcoma.